BACKGROUND/ OBJECTIVES: Cardiovascular disease (CVD) is the leading cause of death in the United States and the world. Clinical trials have suggested that soybean protein lowers lipids and blood pressure. The effect of soybean protein on novel CVD risk factors has not been well studied. The objective of this study was to examine the effect of soybean protein on biomarkers of inflammation, endothelial dysfunction and adipocytokines. SUBJECTS/ METHODS: The effect of 8 weeks of 40 g of soybean protein supplement (89.3 mg isoflavones), 40 g of milk protein supplement and 40 g of complex carbohydrate placebo was examined in a randomized, placebo-controlled, double-blind, three-phase crossover trial among adults in New Orleans, Louisiana and Jackson, Mississippi. Plasma levels of inflammation biomarkers (C-reactive protein, interleukin-6, tumor necrosis factor-α), endothelial dysfunction biomarkers (E-selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, thrombomodulin) and adipocytokines (high-molecular weight adiponectin, leptin, resistin) were measured at baseline and at the end of each intervention using immunoturbidimetric and enzyme-linked immunosorbent assay techniques. RESULTS:Soy protein supplementation resulted in a significant mean net change (95% confidence interval) in plasma E-selectin of -3.93 ng/ml (-7.05 to -0.81 ng/ml; P=0.014) compared with milk protein, and in plasma leptin of -2089.8 pg/ml (-3689.3 to -490.3 pg/ml; P=0.011) compared with carbohydrate. There were no significant changes in any other risk factors. CONCLUSIONS:Soy protein supplementation may reduce levels of E-selectin and leptin. Further research is warranted to investigate the mechanisms through which protein may confer protective effects on novel CVD risk factors.
RCT Entities:
BACKGROUND/ OBJECTIVES:Cardiovascular disease (CVD) is the leading cause of death in the United States and the world. Clinical trials have suggested that soybean protein lowers lipids and blood pressure. The effect of soybean protein on novel CVD risk factors has not been well studied. The objective of this study was to examine the effect of soybean protein on biomarkers of inflammation, endothelial dysfunction and adipocytokines. SUBJECTS/ METHODS: The effect of 8 weeks of 40 g of soybean protein supplement (89.3 mg isoflavones), 40 g of milk protein supplement and 40 g of complex carbohydrate placebo was examined in a randomized, placebo-controlled, double-blind, three-phase crossover trial among adults in New Orleans, Louisiana and Jackson, Mississippi. Plasma levels of inflammation biomarkers (C-reactive protein, interleukin-6, tumor necrosis factor-α), endothelial dysfunction biomarkers (E-selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, thrombomodulin) and adipocytokines (high-molecular weight adiponectin, leptin, resistin) were measured at baseline and at the end of each intervention using immunoturbidimetric and enzyme-linked immunosorbent assay techniques. RESULTS: Soy protein supplementation resulted in a significant mean net change (95% confidence interval) in plasma E-selectin of -3.93 ng/ml (-7.05 to -0.81 ng/ml; P=0.014) compared with milk protein, and in plasma leptin of -2089.8 pg/ml (-3689.3 to -490.3 pg/ml; P=0.011) compared with carbohydrate. There were no significant changes in any other risk factors. CONCLUSIONS: Soy protein supplementation may reduce levels of E-selectin and leptin. Further research is warranted to investigate the mechanisms through which protein may confer protective effects on novel CVD risk factors.
Authors: Anna H Wu; Frank Z Stanczyk; Carmen Martinez; Chiu-Chen Tseng; Suzanne Hendrich; Patricia Murphy; Sukanya Chaikittisilpa; Daniel O Stram; Malcolm C Pike Journal: Am J Clin Nutr Date: 2005-05 Impact factor: 7.045
Authors: S J Hwang; C M Ballantyne; A R Sharrett; L C Smith; C E Davis; A M Gotto; E Boerwinkle Journal: Circulation Date: 1997-12-16 Impact factor: 29.690
Authors: Casey M Rebholz; Eleanor E Friedman; Lindsey J Powers; Whitney D Arroyave; Jiang He; Tanika N Kelly Journal: Am J Epidemiol Date: 2012-10-01 Impact factor: 4.897
Authors: Hea Jin Park; Mary Anne Della-Fera; Dorothy B Hausman; Srujana Rayalam; Suresh Ambati; Clifton A Baile Journal: J Nutr Biochem Date: 2008-06-10 Impact factor: 6.048
Authors: Elizabeth J Reverri; Colette D LaSalle; Adrian A Franke; Francene M Steinberg Journal: Mol Nutr Food Res Date: 2014-12-05 Impact factor: 5.914
Authors: Max Norman Tandrup Lambert; Anne Cathrine Thorup; Esben Søvsø Szoscka Hansen; Per Bendix Jeppesen Journal: PLoS One Date: 2017-06-07 Impact factor: 3.240
Authors: Akira Sekikawa; Aya Higashiyama; Brian J Lopresti; Masafumi Ihara; Howard Aizenstein; Makoto Watanabe; Yuefang Chang; Chikage Kakuta; Zheming Yu; Chester Mathis; Yoshihioro Kokubo; William Klunk; Oscar L Lopez; Lewis H Kuller; Yoshihiro Miyamoto; Chendi Cui Journal: Alzheimers Dement (N Y) Date: 2020-10-22